反应条件
1: 7-nitro-3,4-dihydro-4-methyl-2H-1,4-benzodiazepine-2,5-(1H)-dione With potassium tert-butylate in tetrahydrofuran; N,N-dimethyl-formamide
T=0°C; 0.5 h; Inert atmosphere;
2: With diethyl chlorophosphate in tetrahydrofuran; N,N-dimethyl-formamide
T=0°C; 0.5 h; Inert atmosphere;
3: isocyano-acetic acid ethyl ester With potassium tert-butylate in tetrahydrofuran; N,N-dimethyl-formamide
T=0 - 20°C; 2.5 h; Inert atmosphere;
参考文献
GE HEALTHCARE LIMITED; WOODCRAFT, John; JONES, Clare; GAETA, Alessandra; TRIGG, William; JONES, Paul; PLANT, Stuart
Patent: WO2011/42550 A1, 2011 ;
Location in patent: Page/Page column 31-32 ;